Myriad Genetics Inc.

Public Company, Headquarters Location
320 Wakara Way, Salt Lake City, UT 84108-1214, United States
(801)584-3600, (801)584-3640 fax, http://www.myriad.com

Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Developers of therapeutic and predictive medicine products.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Myriad Genetics Inc., News and Information

Research and Markets Offering Report;: Regulatory and Legislative Activities
Wireless News; 1/4/2010; 383 words; ...the addition of Decision Resources, Inc.'s new report "Regulatory and Legislative...Medicis Pharmaceutical - Merck KGaA - Myriad Genetics - Navigenics - Novartis - Otsuka Pharmaceutical...Copyright 2010 Close-Up Media, Inc. All Rights Reserved.

Research and Markets Adds Report: Regulatory and Legislative Activities.
Health & Beauty Close-Up; 12/29/2009; 490 words; ...Markets has announced the addition of Decision Resources, Inc.'s new report "Regulatory and Legislative Activities...ImClone - Knome - Medicis Pharmaceutical - Merck KGaA - Myriad Genetics - Navigenics - Novartis - Otsuka Pharmaceutical - Pathway...

Research and Markets: Regulatory and Legislative Activities: Shaping Biomarker and Diagnostic Use and Driving Personalized Medicine Out Now.
Business Wire; 12/23/2009; 1011 words; ...Decision Resources, Inc.'s new report "Regulatory...purchasing of personal genetics products once it fully...filed a suit against Myriad Genetics regarding Myriad's...Merck KGaA * Myriad Genetics * Navigenics * Novartis...

Myriad Snags Late-Stage Drug in All-Stock Javelin Acquisition.
BIOWORLD Today; 12/21/2009; 864 words; ...parent company, Salt Lake City-based Myriad Pharmaceuticals Inc. is buying Javelin Pharmaceuticals Inc. in an all-stock transaction that gives...Myriad, which was spun out of Myriad Genetics Inc. in July in an effort to separate the...

MYRIAD GENETICS REPORTS ACQUISITION BY CEO MELDRUM (Utah)
US Fed News Service, Including US State News; 12/19/2009; 297 words; WASHINGTON, Dec. 19 -- Myriad Genetics Inc. (MYGN), Salt Lake City, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.